Table 4.
sHpx and uHpx levels in the patient groups according to the treatment modality (group IIA—only GCS, IIB—GCS with immunosuppressive sparing agents). Data are presented as median values and interquartile ranges.
| Group Parameter |
IIA Relapse N = 26 |
IIB Relapse N = 22 |
IIA Remission N = 17 |
IIB Remission N = 17 |
|---|---|---|---|---|
| sHpx [ng/mL] |
108.2 (97.2–123.6) |
103.4 (95.6–108.8) |
51.2 (42.0–55.6) |
51.2 (49.2–53.6) |
| uHpx [ng/mL] |
103.0 (57.2–158.0) a |
61.1 (55.2–81.4) |
24.8 (22.1–27.5) b |
31.1 (27.5–35.0) |
a—group IIA vs. IIB, p = 0.026; b—group IIA vs. IIB, p = 0.0017.